Table 3. Multivariate Analysis Evaluating the Impact of CMV Infection on the Outcomes of Severe Disease, Mortality, Length of Stay and Total Hospitalization Charges Among All Patients With Ulcerative Colitis and Crohn’s Disease.
| Parameters | Ulcerative colitis |
Crohn’s disease |
||
|---|---|---|---|---|
| Adjusted odds ratio (95% CI) | P value | Adjusted odds ratio (95% CI) | P value | |
| In-hospital mortality | 2.87 (1.36 - 6.06) | 0.005 | 4.26 (1.14 - 15.86) | 0.03 |
| IBD severity | ||||
| Low | Reference | Reference | ||
| Intermediate | 2.27 (1.86 - 2.76) | < 0.001 | 2.35 (1.77 - 3.10) | P < 0.001 |
| Severe | 3.38 (2.49 - 4.60) | < 0.001 | 2.08 (1.20 - 3.60) | P < 0.01 |
| Average difference | P value | Average difference | P value | |
| Length of stay (in days) | 11.71 (10.96 - 12.45) | < 0.001 | 3.97 (3.04 - 4.89) | < 0.001 |
| Total hospitalization costs | $61,304 (54,397 - 68,211) | < 0.001 | $64,157 (55,499 - 72,815) | < 0.001 |
IBD: inflammatory bowel disease; CMV: cytomegalovirus; CI: confidence interval.